hypoglycemic 20-hydroxylecdysone derivative (Chongqing Zhien Pharmaceutical)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namehypoglycemic 20-hydroxylecdysone derivative (Chongqing Zhien Pharmaceutical)
Drug Alias Name20-hydroxylecdysono-20,22-phosphoric acid
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesZein Bioteccnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZein Bioteccnology Co Ltd
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A